Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager

Magle Chemoswed Holding AB

STO:MAGLE

Watchlist

Discount Rate

Price: 39 SEK -1.02%

Market Cap: 421.2m SEK

Have any thoughts about
Magle Chemoswed Holding AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 39 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MAGLE Alert

Magle Chemoswed Holding AB

-0.4 (-1.02%)

52 Week Range	22.4 46
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Magle Chemoswed Holding AB

What unique competitive advantages
does Magle Chemoswed Holding AB hold over its rivals?

What risks and challenges
does Magle Chemoswed Holding AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Magle Chemoswed Holding AB.

What unique competitive advantages
does Magle Chemoswed Holding AB hold over its rivals?

What risks and challenges
does Magle Chemoswed Holding AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Magle Chemoswed Holding AB.

Provide P/S
for Magle Chemoswed Holding AB.

Provide P/E
for Magle Chemoswed Holding AB.

Provide P/OCF
for Magle Chemoswed Holding AB.

Provide P/FCFE
for Magle Chemoswed Holding AB.

Provide P/B
for Magle Chemoswed Holding AB.

Provide EV/S
for Magle Chemoswed Holding AB.

Provide EV/GP
for Magle Chemoswed Holding AB.

Provide EV/EBITDA
for Magle Chemoswed Holding AB.

Provide EV/EBIT
for Magle Chemoswed Holding AB.

Provide EV/OCF
for Magle Chemoswed Holding AB.

Provide EV/FCFF
for Magle Chemoswed Holding AB.

Provide EV/IC
for Magle Chemoswed Holding AB.

Show me price targets
for Magle Chemoswed Holding AB made by professional analysts.

What are the Revenue projections
for Magle Chemoswed Holding AB?

How accurate were the past Revenue estimates
for Magle Chemoswed Holding AB?

What are the Net Income projections
for Magle Chemoswed Holding AB?

How accurate were the past Net Income estimates
for Magle Chemoswed Holding AB?

What are the EPS projections
for Magle Chemoswed Holding AB?

How accurate were the past EPS estimates
for Magle Chemoswed Holding AB?

What are the EBIT projections
for Magle Chemoswed Holding AB?

How accurate were the past EBIT estimates
for Magle Chemoswed Holding AB?

Compare the revenue forecasts
for Magle Chemoswed Holding AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Magle Chemoswed Holding AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Magle Chemoswed Holding AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Magle Chemoswed Holding AB compared to its peers.

Compare the P/E ratios
of Magle Chemoswed Holding AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Magle Chemoswed Holding AB with its peers.

Analyze the financial leverage
of Magle Chemoswed Holding AB compared to its main competitors.

Show all profitability ratios
for Magle Chemoswed Holding AB.

Provide ROE
for Magle Chemoswed Holding AB.

Provide ROA
for Magle Chemoswed Holding AB.

Provide ROIC
for Magle Chemoswed Holding AB.

Provide ROCE
for Magle Chemoswed Holding AB.

Provide Gross Margin
for Magle Chemoswed Holding AB.

Provide Operating Margin
for Magle Chemoswed Holding AB.

Provide Net Margin
for Magle Chemoswed Holding AB.

Provide FCF Margin
for Magle Chemoswed Holding AB.

Show all solvency ratios
for Magle Chemoswed Holding AB.

Provide D/E Ratio
for Magle Chemoswed Holding AB.

Provide D/A Ratio
for Magle Chemoswed Holding AB.

Provide Interest Coverage Ratio
for Magle Chemoswed Holding AB.

Provide Altman Z-Score Ratio
for Magle Chemoswed Holding AB.

Provide Quick Ratio
for Magle Chemoswed Holding AB.

Provide Current Ratio
for Magle Chemoswed Holding AB.

Provide Cash Ratio
for Magle Chemoswed Holding AB.

What is the historical Revenue growth
over the last 5 years for Magle Chemoswed Holding AB?

What is the historical Net Income growth
over the last 5 years for Magle Chemoswed Holding AB?

What is the current Free Cash Flow
of Magle Chemoswed Holding AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Magle Chemoswed Holding AB.

MAGLE

Balance Sheet

Total Liabilities & Equity

Magle Chemoswed Holding AB
Total Liabilities & Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Magle Chemoswed Holding AB
Total Liabilities & Equity Peer Comparison

Comparables:

ALIF B

BICO

BIOT

GENO

MCAP

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company		Total Liabilities & Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
M	Magle Chemoswed Holding AB STO:MAGLE	Total Liabilities & Equity kr273m	CAGR 3-Years 11%	CAGR 5-Years 12%	CAGR 10-Years N/A
	AddLife AB STO:ALIF B	Total Liabilities & Equity kr12.7B	CAGR 3-Years 45%	CAGR 5-Years 37%	CAGR 10-Years N/A
	BICO Group AB STO:BICO	Total Liabilities & Equity kr6.1B	CAGR 3-Years 34%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Biotage AB STO:BIOT	Total Liabilities & Equity kr4.8B	CAGR 3-Years 51%	CAGR 5-Years 31%	CAGR 10-Years 24%
G	Genovis AB STO:GENO	Total Liabilities & Equity kr303.4m	CAGR 3-Years 42%	CAGR 5-Years 48%	CAGR 10-Years 25%
	MedCap AB (publ) STO:MCAP	Total Liabilities & Equity kr1.9B	CAGR 3-Years 20%	CAGR 5-Years 19%	CAGR 10-Years 13%

What is Magle Chemoswed Holding AB's Total Liabilities & Equity?

Total Liabilities & Equity
273m SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Total Liabilities & Equity amounts to 273m SEK.

What is Magle Chemoswed Holding AB's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 5Y
12%

Over the last year, the Total Liabilities & Equity growth was 8%. The average annual Total Liabilities & Equity growth rates for Magle Chemoswed Holding AB have been 11% over the past three years , 12% over the past five years .

Magle Chemoswed Holding AB
STO:MAGLE

Magle Chemoswed Holding AB
Total Liabilities & Equity

Magle Chemoswed Holding AB
Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

See Also

What is Magle Chemoswed Holding AB's Total Liabilities & Equity?

Total Liabilities & Equity
273m SEK

What is Magle Chemoswed Holding AB's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 5Y
12%

Company

Help

Tools

Stocks

Magle Chemoswed Holding AB STO:MAGLE

Magle Chemoswed Holding AB Total Liabilities & Equity

Magle Chemoswed Holding AB Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis Latest Figures & CAGR of Competitors

See Also

What is Magle Chemoswed Holding AB's Total Liabilities & Equity? Total Liabilities & Equity 273m SEK

What is Magle Chemoswed Holding AB's Total Liabilities & Equity growth rate? Total Liabilities & Equity CAGR 5Y 12%

Company

Help

Tools

Stocks

Magle Chemoswed Holding AB
STO:MAGLE

Magle Chemoswed Holding AB
Total Liabilities & Equity

Magle Chemoswed Holding AB
Total Liabilities & Equity Peer Comparison

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

What is Magle Chemoswed Holding AB's Total Liabilities & Equity?

Total Liabilities & Equity
273m SEK

What is Magle Chemoswed Holding AB's Total Liabilities & Equity growth rate?

Total Liabilities & Equity CAGR 5Y
12%